isirv Antiviral Group
Norio Sugaya, Keiyu Hospital, Japan
Norio Sugaya, M.D., is a pediatrician and the Director of Keiyu Hospital in Yokohama City, Japan. He received his PhD from the Keio University School of Medicine for a thesis on diagnostic testing for influenza virus infection. He has been active in the area of influenza vaccines for children and the mass vaccination programs for schoolchildren for over 15 years.
His international experience includes participation as a member of the Pharmacological Management of Pandemic Influenza A (H1N1) panel, held in 2009 at World Health Organization in Geneva and a member of Multinational Influenza Seasonal Mortality Study of NIH/FIC. He is also a central member of committees examining pandemic influenza under the auspices of the Japanese Association for Infectious Diseases and the Japan Pediatric Society.
His current research involves the study of the effectiveness of neuraminidase inhibitors, including newly approved drugs such as laninamivir and peramivir. He is also participating the GLaMOR NIVEL-WHO project to estimate the global burden of 2009 pandemic influenza.
